| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183433 Ionic liquids and their use as solvents |
| 02/27/2007 | US7183320 For therapy of neoplastic diseases |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/22/2007 | WO2007020636A1 Printable materials |
| 02/22/2007 | WO2006134212A3 Preparation of tamsulosin hydrochloride from tamsulosi |
| 02/22/2007 | WO2006103261A3 Inhibitors of neurotrypsin and determination thereof |
| 02/22/2007 | WO2006002185A8 Chemical compounds |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/21/2007 | EP1753714A2 2-substituted and 4-substituted aryl nitrone compouds |
| 02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917870A Compounds and compositions as lxr modulators |
| 02/20/2007 | US7179923 N-sulfonylaminocarbonyl containing compounds |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa |
| 02/15/2007 | US20070037813 Serine Protease Inhibitors |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 02/15/2007 | CA2618481A1 Compounds for treating alzheimer's disease |
| 02/15/2007 | CA2618474A1 Compounds for treating alzheimer's disease |
| 02/14/2007 | EP1751097A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 02/14/2007 | EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 02/14/2007 | EP1751090A1 Acid derivatives of substituted cyclohexyl-1,4-diamines |
| 02/14/2007 | CN1914169A Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/14/2007 | CN1300103C 4-iodine-2-{N-(N-alkyl amino carbonyl)-aminosulfuryl} benzaformic carbonmethooxy, preparation method thereof and method for preparing iodo compound using same |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/08/2007 | WO2007015809A2 Hiv reverse transcriptase inhibitors |
| 02/08/2007 | WO2007015724A1 Tromethamine salt of valproic acid |
| 02/08/2007 | WO2007014847A1 Stable aqueous dispersions of colour developer |
| 02/08/2007 | WO2006109175A3 Solid dosage form of an antidiabetic drug |
| 02/08/2007 | US20070032658 Reacting an N-protected diphenylalanine with an optically active 1-phenyl- or 1-naphthyl-ethylamine and separating (crystal precipitation) the resulting diastereomeric salt; converting to free acid; deprotecting; synthetic intermediate for anti-HIV drugs and dipeptidyl peptidase inhibitors |
| 02/08/2007 | US20070031326 Compounds that selectively bind to membranes of apoptotic cells |
| 02/08/2007 | CA2616516A1 Stable aqueous dispersions of colour developer |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | CN1910144A Sulfonamide derivatives for the treatment of diseases |
| 02/07/2007 | CN1910143A Sulfonamide derivatives for the treatment of diseases |
| 02/07/2007 | CN1910141A Diamino alcohols and their use as renin inhibitors |
| 02/07/2007 | CN1910135A Amino alcohol derivatives and their activity as renin inhibitors |
| 02/07/2007 | CN1909897A Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/01/2007 | WO2007013929A1 Aniline sulfonamide derivatives and their uses |
| 02/01/2007 | WO2006132811A3 Ampa receptor potentiators |
| 02/01/2007 | CA2615718A1 Aniline sulfonamide derivatives and their uses |
| 01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
| 01/31/2007 | EP1747212A2 Process for making n-sulfonated-amino acid derivatives |
| 01/31/2007 | EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1906181A N-sulfonylaminocarbonyl containing compounds |
| 01/31/2007 | CN1906154A Aminoalcohol derivatives |
| 01/31/2007 | CN1903835A Compound, composition and method for preventing neurodegeneration in acute and chronic injury of central nervous system |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/30/2007 | US7169955 Perfluoroisopropylbenzene derivative |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169933 Immobilization of compounds with connector groups of amines |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2144133C Monomers derived from perhalogenated sultones and polymers produced from said monomers |
| 01/30/2007 | CA2126917C New n-phenyl 2-cyano 3-hydroxy propenamides; tautomers and salts thereof; process for preparing them and their use as therapeutic agents; compositions containing these new product |
| 01/25/2007 | WO2007010356A2 Process for the preparation of sulfonamide derivatives |
| 01/25/2007 | WO2007009798A2 Process of sulfonating 4-aminobenzonitriles |
| 01/25/2007 | WO2005118527A3 Fluorous capping reagents, and methods for peptide purification |
| 01/25/2007 | US20070021502 Aniline sulfonamide derivatives and their uses |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | CA2615437A1 Process of sulfonating 4-aminobenzonitriles |
| 01/24/2007 | CN1902244A Water- and oil-repellent fluoroacrylates |
| 01/24/2007 | CN1902166A Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |
| 01/24/2007 | CN1902165A Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 01/24/2007 | CN1902164A Process for preparing fluorochemical monoisocyanates |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1900059A 2-keto naphthene sulfamide, its preparing method and use as germicide |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166744 Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds |
| 01/23/2007 | US7166738 viricides; polymerase inhibitors; therapy for genetic engineered virus |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166418 Sulfonamide compound, polymer compound, resist material and pattern formation method |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2006091870A3 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
| 01/18/2007 | US20070015939 Hydrochloride of benzenesulfonamide compound with the ether compound to obtain the tamsulosin |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/18/2007 | CA2613458A1 Compounds with activity at retinoic acid receptors |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1453852B1 Selective urokinase inhibitors |
| 01/17/2007 | EP1363878B1 Process for preparing sulfamoyl-substituted phenethylamine derivatives |